Literature DB >> 11252101

Perioperative management of cosmetic liposuction.

R H de Jong1, F M Grazer.   

Abstract

Recent qualms about the safety of aesthetic lipoplasty may be attributable more to support system flaws than to technical process deficiencies. The authors here focus on perfunctory patient monitoring when sedative or analgesic drugs are given, cavalier infiltration of mega-dose lidocaine, cursory intraoperative patient observation by team members with conflicting responsibilities, anesthesia providers unfamiliar with the unique surgical physiology of liposuction, hurried-discharge policies that virtually ignore the residual depressant effects of sedatives and analgesics, and compressive dressings that impair postoperative chest-wall expansion and venous return. Whereas pulmonary embolism remains the leading process cause of morbidity from liposuction, complications from austere resource allocation to dedicated patient monitoring should be largely preventable. Not all lipoplasties require an anesthesia provider but-when heavy sedation, mega-dose lidocaine, or both, are projected-a trained team member dedicated exclusively to patient safety and comfort should be a minimum patient care standard. The potential role of lidocaine cardiotoxicity in tumescent anesthesia is widely underappreciated and that of hypothermia goes mostly unrecognized. These, plus largely preventable or potentially correctable perioperative events such as pulmonary edema, fluid imbalance, or improperly administered sedative and analgesic drugs, demand upgrading and expansion of monitoring, resuscitative, and recuperative facilities in physician offices. In fact, ASPS guidelines urge that anesthesia services be engaged for dedicated patient care whenever "major" liposuction or conscious sedation is projected, because liposuction is neither as benign nor as simple a procedure as heretofore reputed. To assess objectively the operative and anesthetic risk of obesity, document body mass index for the preoperative record; morbid obesity (body mass index >/= 35.0), for instance, is a known risk multiplier for sedatives and analgesics. Other system issues such as the dynamic profile of high-dose lidocaine pharmacokinetics, the deportation of fat globules in the bloodstream, and the incidence of intraoperative hypothermia remain as unresolved topics for interdisciplinary, multi-institutional clinical research.

Entities:  

Mesh:

Year:  2001        PMID: 11252101     DOI: 10.1097/00006534-200104010-00022

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  7 in total

1.  [Complications of liposuction].

Authors:  G Sattler; S Eichner
Journal:  Hautarzt       Date:  2013-03       Impact factor: 0.751

2.  Liposuction infiltration: The Quito formula - a new approach based on an old concept.

Authors:  Iván Marcelo Cueva Galárraga
Journal:  Can J Plast Surg       Date:  2011

3.  Safe limits for aspirate volume under wet liposuction.

Authors:  João Cantarelli; Moacir F Godoy
Journal:  Obes Surg       Date:  2009-12       Impact factor: 4.129

Review 4.  [Body contouring].

Authors:  N Krüger; S Lübberding; G Sattler
Journal:  Hautarzt       Date:  2015-10       Impact factor: 0.751

5.  Perioperative evaluation of tumescent anaesthesia technique in bitches submitted to unilateral mastectomy.

Authors:  Leonardo de Freitas Guimaraes Arcoverde Credie; Stelio Pacca Loureiro Luna; Fabio Futema; Luciano Cacciari Baruffaldi Almeida da Silva; Giancarlo Bressane Gomes; Jaqueline Neratika Negrette Garcia; Lidia Raquel de Carvalho
Journal:  BMC Vet Res       Date:  2013-09-11       Impact factor: 2.741

6.  Hypoxia after abdominal and thigh liposuction: pulmonary embolism or fat embolism?

Authors:  L Cohen; R Engdahl; G Latrenta
Journal:  Eplasty       Date:  2014-07-17

Review 7.  Plastic Surgery Complications: A Review for Emergency Clinicians.

Authors:  Tim Montrief; Kasha Bornstein; Mark Ramzy; Alex Koyfman; Brit J Long
Journal:  West J Emerg Med       Date:  2020-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.